Please wait while the formulary information is being retrieved.
JARRO-DOPHILUS EPS (Lactobac no.19/Bifidobac breve,longum/Lactoc lactis/P. acidi)
25 billion cell capsule,delayed release
- Dosage information is not available
5 billion cell capsule,delayed release
- Dosage information is not available
50 billion cell capsule,delayed release
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- None
JARRO-DOPHILUS EPS (Lactobac no.19/Bifidobac breve,longum/Lactoc lactis/P. acidi)
- None
- None
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Bifidobacteria Bifidum
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool